CLDN18 plays a tumour suppressor role in gastric and lung cancers but functions as a tumour promoter in other cancers of the GI tract, including oesophageal, pancreatic, colorectal and bile duct cancers, which is consistent with the ectopic expression pattern described above. This evidence concerns the gene CLDN18 and cancer.